# Replimune Group, Inc.: Form 8-K, filed Jun 3, 2020

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2020-06-03
- Accepted by EDGAR: Jun 3, 2020, 07:26 ET
- Period: 2020-06-01
- Accession: 0001104659-20-069223
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465920069223/tm2021674d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465920069223/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465920069223/tm2021674d1_8k.htm

Filed Jun 3, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-069223. Last ingested by Listed: Nov 11, 2026, 01:43 ET. No prices; not investment advice.